Cheng Luo

机构：Guangzhou University of Chinese Medicine, Nanjing University of Chinese Medicine, Central South University, Guiyang Medical University, University of Electronic Science and Technology of China, Guangdong Medical College, Chinese Academy of Sciences, Peking University, Affiliated Hospital of Guizhou Medical University, Shanghai Institute of Materia Medica, Drug Discovery Laboratory (Norway), Xiangya Hospital Central South University, Center for Life Sciences, University of Chinese Academy of Sciences, State Key Laboratory of Drug Research, Chengdu University of Traditional Chinese Medicine, Southern Medical University · ORCID：0000-0003-3864-8382

发表论文 621 篇 · 总被引 19536 次 · h-index 66

代表论文

• mTORC1‐USP30‐LEF1 Cascade Regulates Cancer Stemness and Malignant Progression Through Mitonuclear Crosstalk (2025 · MedComm · 被引 3)
• Mechanisms of phosphorus release from coastal sediments driven by organic matter enrichment at high nitrogen concentrations (2025 · Marine Pollution Bulletin · 被引 2)
• Discovery of a Novel DNMT1 Inhibitor with Improved Efficacy in Treating β‐Thalassemia (2025 · Advanced Science · 被引 2)
• Whole-gene CRISPR/cas9 library screen revealed targeting STAT6 increased the sensitivity of liver cancer to celecoxib via inhibiting arachidonic acid shunting (2025 · Cell Communication and Signaling · 被引 2)
• Expansion of functional human long-term HSCs through restraining excessive cell cycle activation (2026 · Blood)
• Author Correction: A peptide-centric local stability assay enables proteome-scale identification of the protein targets and binding regions of diverse ligands (2026 · Nature Methods)